HeartSciences Balance Sheet Health

Financial Health criteria checks 5/6

HeartSciences has a total shareholder equity of $5.9M and total debt of $500.0K, which brings its debt-to-equity ratio to 8.4%. Its total assets and total liabilities are $8.2M and $2.3M respectively.

Key information

8.4%

Debt to equity ratio

US$500.00k

Debt

Interest coverage ration/a
CashUS$4.34m
EquityUS$5.93m
Total liabilitiesUS$2.26m
Total assetsUS$8.19m

Recent financial health updates

Recent updates

HeartSciences granted U.S patent for ECG assessment of heart

Sep 20

Heart Test Laboratories reports Q1 results

Sep 13

Financial Position Analysis

Short Term Liabilities: HSCS's short term assets ($6.1M) exceed its short term liabilities ($1.4M).

Long Term Liabilities: HSCS's short term assets ($6.1M) exceed its long term liabilities ($905.7K).


Debt to Equity History and Analysis

Debt Level: HSCS has more cash than its total debt.

Reducing Debt: Insufficient data to determine if HSCS's debt to equity ratio has reduced over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: HSCS has sufficient cash runway for 8 months based on last reported free cash flow, but has since raised additional capital.

Forecast Cash Runway: HSCS is forecast to have sufficient cash runway for 7 months based on free cash flow estimates, but has since raised additional capital.


Discover healthy companies